Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactospey Enteric Ecol
- Development stage
- Unknown
- Lead developer
- Spey Medical
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Lactospey Enteric Ecol is an oral probiotic and prebiotic supplement developed by SPEY to support gastrointestinal health and manage digestive disorders. It is formulated as capsules containing the probiotic yeast *Saccharomyces boulardii*, a probiotic bacterial blend (including *Lactobacillus acidophilus*, *Lactobacillus casei*, and *Bifidobacterium* species), and the prebiotic inulin. The combination of these beneficial microorganisms and prebiotics helps restore and maintain normal intestinal microflora, inhibit the growth of pathogenic bacteria, and neutralize toxins. Lactospey Enteric Ecol is approved for the prevention and treatment of acute and chronic diarrhea, colitis, irritable bowel syndrome, and *Clostridium difficile* infections, particularly during or after antibiotic therapy.
- Brand names
- Lactospey Enteric Ecol
Beyond the preview
Go deeper on Lactospey Enteric Ecol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lactospey Enteric Ecol.